🇺🇸 FDA
Pipeline program

AVI-4065 Injection

AVI-4065-20

Phase 2 small_molecule terminated

Quick answer

AVI-4065 Injection for Hepatitis C is a Phase 2 program (small_molecule) at Sarepta Therapeutics with 1 ClinicalTrials.gov record(s).

Program details

Company
Sarepta Therapeutics
Indication
Hepatitis C
Phase
Phase 2
Modality
small_molecule
Status
terminated

Clinical trials